Le Lézard
Classified in: Health

Noura B. Moussa, DDS, is being recognized by Continental Who's Who


WASHINGTON, March 30, 2020 /PRNewswire/ -- Noura B. Moussa, DDS, is being recognized by Continental Who's Who as a Top Dentist in the field of Medicine as a General and Cosmetic Dentist at Davidson Dental Associates.

Offering her services at 1990 K St NW, Dr. Moussa has gained esteemed recognition in her community for being a relatable, kind, and gentle dentist. With over seven years of professional excellence, she is adept at general and cosmetic dentistry such as veneers, implant restoration and Invisalign.

Devoted to offering top quality dental work, Dr. Moussa aims to always remain up to date. She is constantly learning more about dentistry and the human body, searching for effective, accurate methods of good oral care. Holding the highest ethical standards, she treats each patient like family and teaches them the importance of good oral care for overall healthy living.

In preparation for her career, Dr. Moussa received a Bachelor of Science (BS) from George Mason University, one of top 153 universities in the U.S. Furthering her education, she received a Doctorate of Dental Surgery from the fifth oldest dental school, the College of Dentistry at Howard University. She is licensed to practice by the state board in the District of Columbia and Maryland.

To remain abreast of changes in her field, Dr. Moussa maintains affiliations with the American Dental Association (ADA), DC Dental Society (DCDS), and GWADS Study Club.

As a testament to Dr. Moussa's success, ADA nominated her for 10 Under 10 in 2018 and America Top Dentist recognized her from 2015 to 2018.

Dr. Moussa dedicates this recognition to her husband Sameh and children Yousef, Kareem, and Nada. She expresses gratitude to her parents Asma and Badie and mentor Dr. Terri Matthews at Howard University.

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE Continental Who's Who


These press releases may also interest you

at 03:26
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...



News published on and distributed by: